Oaktree appoints banks for planned sale of SGD Pharma: Reuters

Oaktree Capital (OAK.N) plans to sell its stake in SGD Pharma, a French company that specializes in making glass packaging for the pharmaceutical sector, and has mandated JP Morgan (JPM.N) and Lazard (LAZ.N) to drive the process, two sources close to the deal told Reuters on Friday.

16 February 2016•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles